We are live on ! Find out more
ESE icon

ESCO Technologies

200 hedge funds and large institutions have $2.01B invested in ESCO Technologies in 2022 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 64 increasing their positions, 71 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

325% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 8

13% more funds holding

Funds holding: 177200 (+23)

11% more capital invested

Capital invested by funds: $1.8B → $2.01B (+$202M)

10% less repeat investments, than reductions

Existing positions increased: 64 | Existing positions reduced: 71

6.51% less ownership

Funds ownership: 95.01%88.49% (-6.5%)

Holders
200
Holders Change
+23
Holders Change %
+12.99%
% of All Funds
3.21%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
34
Increased
64
Reduced
71
Closed
8
Calls
Puts
Net Calls
Net Calls Change

ESE Hedge Fund Activity: Q4 2022 in Review

200 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in ESCO Technologies (ESE) for Q4 2022, worth a combined $2.01B — up 11% from $1.8B a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new ESE positions and 8 closed out — a net gain of 26 holders — while 64 added to existing stakes and 71 trimmed.

The largest buyer was BlackRock, adding an estimated $5.55M. The largest seller was T. Rowe Price Investment Management, cutting an estimated $10.8M.

  • 200 institutional investors held ESCO Technologies (ESE) as of Q4 2022, up from 177 in Q3 2022.
  • Funds reported $2.01B of ESCO Technologies stock for Q4 2022, up 11% quarter-over-quarter.
  • 34 funds opened new ESCO Technologies positions in Q4 2022 and 8 closed out, a net change of +26 holders.
  • The largest ESCO Technologies buyer in Q4 2022 was BlackRock, an estimated $5.55M added.
  • The largest ESCO Technologies seller in Q4 2022 was T. Rowe Price Investment Management, an estimated $10.8M sold.

Based on aggregated 13F filings for Q4 2022.